Wolverine Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Wolverine Trading’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	-$3.2K	–	5396
2023 Q3	$3.2K	Buy	+5	New	+$21.4K	﹤0.01%	4387
2023 Q2	–	Sell	-12	Closed	-$33K	–	5127
2023 Q1	$33K	Buy	12 +4	+50%	+$11.7K	﹤0.01%	3919
2022 Q4	$21K	Sell	8 -3	-27%	-$10.5K	﹤0.01%	3731
2022 Q3	$44K	Buy	+11	New	+$43.3K	﹤0.01%	4183
2022 Q1	–	Sell	-5	Closed	-$34K	–	6694
2021 Q4	$34K	Buy	+5	New	+$38.4K	﹤0.01%	5423

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's SEEL Position: Q4 2022 in Review

Wolverine Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 3 shares — an estimated $10.5K sold.

Wolverine Trading first reported a position in SEEL in Q3 2022 and held it in 1 quarter. The position peaked at $14K in Q3 2022. 63 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.

Wolverine Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wolverine Trading sold 3 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $10.5K.
Wolverine Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Wolverine Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $14K in Q3 2022.
63 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.